2020
DOI: 10.3390/molecules25214882
|View full text |Cite
|
Sign up to set email alerts
|

The Budesonide-Hydroxypropyl-β-Cyclodextrin Complex Attenuates ROS Generation, IL-8 Release and Cell Death Induced by Oxidant and Inflammatory Stress. Study on A549 and A-THP-1 Cells

Abstract: Synthetic glucocorticoids such as budesonide (BUD) are potent anti-inflammatory drugs commonly used to treat patients suffering from chronic inflammatory diseases. A previous animal study reported a higher anti-inflammatory activity with a 2-hydroxypropyl-β-cyclodextrin (HPβCD)-based formulation of BUD (BUD:HPβCD). This study investigated, on cellular models (A549 and A-THP-1), the effect of BUD:HPβD in comparison with BUD and HPβCD on the effects induced by oxidative and inflammatory stress as well as the rol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 70 publications
0
4
0
Order By: Relevance
“…As suggested by other authors, HPβCD can reduce ROS production via cholesterol depletion in oxidative stress-induced cells. 39,40 As tolcapone showed to induce lipid accumulation in hepatic cells by promoting hepatocellular triglyceride accumulation in another study, we hypothesize that HPβCD might have a role in lipid metabolism, protecting the cells from impairments caused by drugs. 13 For the moment, and to the best of our knowledge, the exact mechanisms of how HPβCD, and cyclodextrin, in general, protects cells remain elusive.…”
Section: Discussionmentioning
confidence: 76%
See 1 more Smart Citation
“…As suggested by other authors, HPβCD can reduce ROS production via cholesterol depletion in oxidative stress-induced cells. 39,40 As tolcapone showed to induce lipid accumulation in hepatic cells by promoting hepatocellular triglyceride accumulation in another study, we hypothesize that HPβCD might have a role in lipid metabolism, protecting the cells from impairments caused by drugs. 13 For the moment, and to the best of our knowledge, the exact mechanisms of how HPβCD, and cyclodextrin, in general, protects cells remain elusive.…”
Section: Discussionmentioning
confidence: 76%
“…Indeed other works have pointed out that HPβCD can reduce ROS production via cholesterol depletion in oxidative stress-induced cells, thus exhibiting antioxidant and anticytotoxic properties. 39,40 The PLGA-GAL@Tolc formulation was unable to reduce ROS production in both media, except for the formulation tested at 50 μM in glucose medium (Figure 7a), where ROS production was increased. These results suggest that HPβCD might have a dual function in the formulation: cryoprotection of NPs and an anticytotoxic effect, protecting cells from tolcapone ROSinduced aggression.…”
Section: Lyophilization Optimizationmentioning
confidence: 99%
“…Finally, regarding the anti-inflammatory activity of the isolated compounds, compound 1 is a glucocorticoid with powerful antiinflammatory effects [38] that is used to treat chronic inflammatory diseases [39]. However, although compound 1 was isolated as a mixture of diastereoisomers, they do not show significant structural differences, so the activity of both structures can be assumed to be similar.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, NLRP3, one of the most well-known inflammasomes, has been shown to mediate the inflammatory response in intestinal disorders via an oxidative stress mechanism [63][64][65]. Thus, to understand whether the NLRP3 inflammasome could be activated in human intestinal cells in response to an oxidative stimulus, and to evaluate whether formulations containing budesonide could prevent an oxidative stress-related inflammatory response, as already evidenced [66], we triggered CaCo2 cells with the oxidoreductase enzyme glucose oxidase (GO), able to induce the production of hydrogen peroxide (H 2 O 2 ) via glucose oxidation as previously described [67].…”
Section: Immunofluorescence Nlrp3-asc and Elisa Il-1βmentioning
confidence: 99%